Bristol Myers Squibb and Incyte Forge Notable AI Collaborations
Bristol Myers Squibb and Incyte are making significant strides in AI integration within their operations, focusing on enhancing drug development processes and accelerating timelines to market.
More from this archive
Google DeepMind Expands Talent Pool with Contextual AI Acquisition
Google DeepMind has secured over 20 researchers from Contextual AI in a deal valued between $80M and $90M,…
Bristol Myers Squibb Teams Up with Anthropic to Revolutionise AI Integration
Bristol Myers Squibb has partnered with Anthropic to integrate advanced AI capabilities into its operations, aiming to boost…
Ilon Musk’s xAI Accelerates Grok Build with Daily Updates
Ilon Musk's xAI has announced daily updates for Grok Build, an AI coding assistant, enhancing performance amid intensifying…
Nvidia’s Earnings Report: Key Insights on the AI Economy
As Nvidia prepares to unveil its first-quarter earnings, analysts focus on the implications for the AI economy and…
The archive
sorted by latest
Newegg’s AMD Gaming Bundle Offers Major Savings for High-Performance Builds
GPUBeat Desk · 2 min
Harvard Paper Highlights Governance Risks in AI Firms OpenAI and Anthropic
GPUBeat Desk · 2 min
AI Accelerates Research on Pathogen-Induced Diseases
GPUBeat Desk · 2 min
Anthropic’s $200B Deal with Google Cloud Signals AI Compute Shift
GPUBeat Desk · 2 min
Netflix’s Maternal Instinct Explores a Disturbing Pregnancy Deception
GPUBeat Desk · 2 min